Report Feature
Drug Discovery Services Market Trends and Forecast
The future of the global drug discovery services market looks promising with opportunities in the pharmaceutical & biotechnology companies and academic institute markets. The global drug discovery services market is expected to reach an estimated $37.3 billion by 2028 with a CAGR of 14.1% from 2023 to 2028. The major drivers for this market are increasing need for drug discovery services with growing cases of various diseases, growing demand for specialized testing services among end users, and rising research activity on unidentified drugs.
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
Drug Discovery Services Market by Segment
The study includes a forecast for the global drug discovery services market by process, type, drug type, therapeutic area, end users, and region, as follows:
Drug Discovery Services Market by Process [Value ($B) Shipment Analysis from 2017 to 2028]:
- Target Selection
- Target Validation
- Hit-to-Lead Identification
- Lead Optimization
- Candidate Validation
Drug Discovery Services Market by Type [Value ($B) Shipment Analysis from 2017 to 2028]:
- Chemistry Services
- Biology Services
Drug Discovery Services Market by Drug Type [Value ($B) Shipment Analysis from 2017 to 2028]:
- Small-molecule Drugs
- Biologics
Drug Discovery Services Market by Therapeutic Area [Value ($B) Shipment Analysis from 2017 to 2028]:
- Oncology
- Neurology
- Cardiovascular Diseases
- Respiratory Diseases
- Diabetes and Other Therapeutic Areas
Drug Discovery Services Market by End Users [Value ($B) Shipment Analysis from 2017 to 2028]:
- Pharmaceutical & Biotechnology Companies
- Academic Institutes
- Others
Drug Discovery Services Market by Region [Value ($B) Shipment Analysis from 2017 to 2028]:
- North America
- Europe
- Asia Pacific
- The Rest of the World
List of Drug Discovery Services Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies drug discovery services companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the drug discovery services companies profiled in this report include.
- Eurofins Scientific
- Evotec SE
- Charles River Laboratories International
- GenScript
- Thermo Fisher Scientific
- Oncodesign Services
- ChemPartner Co.
- DiscoverX Corp.
- QIAGEN
- Domainex Ltd
Drug Discovery Services Market Insights
- Lucintel forecasts that chemistry services will remain the largest segment over the forecast period due to growing number of outsourcing projects for small molecules and increasing adoption in academics, biotechnology companies, and large pharmaceutical companies.
- Within this market, pharmaceutical & biotechnology companies is expected to remain the largest segment due to surge in the number of chronic diseases among the elderly population and growing interest of pharmaceutical and biopharmaceutical companies in developing new drugs.
- North America is expected to remain the largest region during the forecast period due to supportive financial investment in the R&D activities by pharmaceutical and biopharmaceutical companies, availability of advanced equipment for continuous drug discovery research, and presence of key CROs in the region.
Features of the Drug Discovery Services Market
- Market Size Estimates: Drug discovery services market size estimation in terms of value ($B)
- Trend and Forecast Analysis: Market trends (2017-2022) and forecast (2023-2028) by various segments and regions.
- Segmentation Analysis: Drug discovery services market size by various segments, such as by process, type, drug type, therapeutic area, end users, and region
- Regional Analysis: Drug discovery services market breakdown by North America, Europe, Asia Pacific, and the Rest of the World.
- Growth Opportunities: Analysis on growth opportunities in different by process, type, drug type, therapeutic area, end users, and regions for the drug discovery services market.
- Strategic Analysis: This includes M&A, new product development, and competitive landscape for the drug discovery services market.
- Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q1. What is the drug discovery services market size?
Answer: The global drug discovery services market is expected to reach an estimated $37.3 billion by 2028.
Q2. What is the growth forecast for drug discovery services market?
Answer: The global drug discovery services market is expected to grow with a CAGR of 14.1% from 2023 to 2028.
Q3. What are the major drivers influencing the growth of the drug discovery services market?
Answer: The major drivers for this market are increasing need for drug discovery services with augmenting cases of various diseases, growing demand for specialized testing services among end users, and rising research activity on unidentified drugs.
Q4. What are the major segments for drug discovery services market?
Answer: The future of the drug discovery services market looks promising with opportunities in the pharmaceutical & biotechnology companies and academic institute markets.
Q5. Who are the key drug discovery services companies?
Answer: Some of the key drug discovery services companies are as follows:
Answer: The global drug discovery services market is expected to reach an estimated $37.3 billion by 2028.
Q2. What is the growth forecast for drug discovery services market?
Answer: The global drug discovery services market is expected to grow with a CAGR of 14.1% from 2023 to 2028.
Q3. What are the major drivers influencing the growth of the drug discovery services market?
Answer: The major drivers for this market are increasing need for drug discovery services with augmenting cases of various diseases, growing demand for specialized testing services among end users, and rising research activity on unidentified drugs.
Q4. What are the major segments for drug discovery services market?
Answer: The future of the drug discovery services market looks promising with opportunities in the pharmaceutical & biotechnology companies and academic institute markets.
Q5. Who are the key drug discovery services companies?
Answer: Some of the key drug discovery services companies are as follows:
- Eurofins Scientific
- Evotec SE
- Charles River Laboratories International
- GenScript
- Thermo Fisher Scientific
- Oncodesign Services
- ChemPartner Co.
- DiscoverX Corp.
- QIAGEN
- Domainex Ltd
Q6. Which drug discovery services segment will be the largest in future?
Answer: Lucintel forecasts that chemistry services will remain the largest segment over the forecast period due to growing number of outsourcing projects for small molecules and increasing adoption in academics, biotechnology companies, and large pharmaceutical companies.
Q7. In drug discovery services market, which region is expected to be the largest in next 5 years?
Answer: North America is expected to remain the largest region during the forecast period due to supportive financial investment in the R&D activities by pharmaceutical and biopharmaceutical companies, availability of advanced equipment for continuous drug discovery research, and presence of key CROs in the region.
Q8. Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% Customization Without any Additional Cost.
Answer: Lucintel forecasts that chemistry services will remain the largest segment over the forecast period due to growing number of outsourcing projects for small molecules and increasing adoption in academics, biotechnology companies, and large pharmaceutical companies.
Q7. In drug discovery services market, which region is expected to be the largest in next 5 years?
Answer: North America is expected to remain the largest region during the forecast period due to supportive financial investment in the R&D activities by pharmaceutical and biopharmaceutical companies, availability of advanced equipment for continuous drug discovery research, and presence of key CROs in the region.
Q8. Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% Customization Without any Additional Cost.
